ADVERTISEMENT
New Frontiers in Vaccine Development
New Frontiers in Vaccine Development
Discover how scientists are designing the next groundbreaking vaccines against infectious diseases.
New Frontiers in Vaccine Development
New Frontiers in Vaccine Development

Discover how scientists are designing the next groundbreaking vaccines against infectious diseases.

Discover how scientists are designing the next groundbreaking vaccines against infectious diseases.

vaccine

An array of green dots, some faded, some bright, on a black background.
Solutions for Accelerating Infectious Disease Research
The Scientist Staff | Nov 15, 2024 | 2 min read
Researchers need a comprehensive toolbox for infectious disease research as they race against the next pandemic.
Two vaccine syringes on a baggy labelled with San Diego Zoo and Bonobo
Can Animals Get Covid and Should They Be Vaccinated?
Chris Baraniuk | Sep 23, 2024 | 7 min read
While covid has caused illness and millions of deaths among humans, multiple nonhuman animal species have turned out to be susceptible to it, too.
An illustration of a B cell secreting autoantibodies.
Autoimmune Diseases: An Alternative Application for Immunotherapy
The Scientist | Aug 23, 2024 | 1 min read
Learn how immunotherapy is revolutionizing autoimmune disorder treatment.
mRNA molecule is manufactured from a ribosome. 
A Twisted Secret that Extends mRNA Longevity in Cells
Maggie Chen | Jun 28, 2024 | 3 min read
By tinkering with branched mRNA structures, scientists lay the groundwork to build better vaccines in the future. 
Vaccines and Beyond: Strategies and Technologies for mRNA Therapeutics
Vaccines and Beyond: Strategies and Technologies for mRNA Therapeutics
The Scientist Staff | Jun 19, 2024 | 2 min read
An expert panel will discuss mRNA-based vaccines, current approaches and challenges, and how researchers are moving RNA therapeutics forward in exciting new directions.
A stock image featuring a render of an influenza virion in the bottom-right corner.
Staying Ahead of Influenza
The Scientist Staff | May 1, 2024 | 2 min read
Researchers access a wide range of tools and reagents to keep pace with seasonal influenza.
New Strategies in the Battle Against Infectious Diseases
New Strategies in the Battle Against Infectious Diseases
The Scientist Staff | Jan 8, 2024 | 2 min read
Learn how the latest research into viral and bacterial pathogens advances the prevention and treatment of infectious diseases. 
Beyond Cytotoxicity: The Importance of T Cell Memory<br ><br>
Beyond Cytotoxicity: The Importance of T Cell Memory
The Scientist | Jan 4, 2024 | 1 min read
In this webinar, Grégoire Lauvau and Marcus Buggert will discuss the function and role of memory T cells in health and disease.
A triangular sign affixed to a tree displaying the silhouette of a tick.
Newly Developed mRNA Vaccine Protects Against Lyme Disease
Charlene Lancaster, PhD | Nov 13, 2023 | 5 min read
Leveraging the same mRNA platform used for COVID-19 vaccines, researchers generated a vaccine that prevents mice from acquiring Lyme disease.
Learn How Researchers Found Antibodies Targeting Omicron SARS-CoV-2 Variants
Searching for Novel Antibodies with Optofluidics-Powered Screening
Phenomenex | Jul 18, 2023 | 1 min read
Vaccination against one SARS-CoV-2 variant can yield antibodies with efficacy against other viral variants.
<em >The Scientist</em>&rsquo;s Journal Club: Immunology
The Scientist’s Journal Club: Immunology
The Scientist | May 2, 2023 | 1 min read
Scientists present the latest research on the immune response against SARS-CoV-2, the influence of COVID-19 on future vaccine responses, and drivers of T cell development.
Dead shark on concrete
Researchers Make Alternatives to Shark-Sourced Vaccine Ingredient
Natalia Mesa, PhD | Feb 22, 2023 | 3 min read
Synthetic variations of squalene, which is used to boost immune responses, could make vaccines more effective while reducing fisheries for struggling sharks.
RSV vaccine design concept art
RSV Vaccines That Work?
Rachael Moeller Gorman | Feb 16, 2023 | 10+ min read
Multiple candidates are in Phase 3 clinical trials for older adults and pregnant women, with some getting close to approval in the United States.
Fluorescence image in purple and green of lymph node
Targeting Antigen “Sanctuary” in Lymph Nodes Could Make Vaccines Better
Natalia Mesa, PhD | Feb 10, 2023 | 3 min read
Researchers find that small sacks inside lymph nodes contain low proteolytic activity and act as safe havens for antigens.
a newly hatched mosquito sits on top of water, with its discarded cocoon floating below
In Vitro Malaria Sporozoite Production May Lead to Cheaper Vaccines
Katherine Irving | Jan 20, 2023 | 4 min read
A method for culturing the infectious stage of the Plasmodium lifecycle could increase malaria vaccine production efficiency by tenfold, study authors say.
Sam Katz looks at the camera
Measles Vaccine Developer Samuel Katz Dies at 95
Lisa Winter | Nov 23, 2022 | 3 min read
He also worked on immunizations against polio, rubella, influenza, and more.
person in white jacket putting bandaid on arm of child
Can We Predict How Well Someone Will Respond to a Vaccine?
Natalia Mesa, PhD | Nov 14, 2022 | 7 min read
Researchers find signatures pre- and post-vaccination that correlate with a more robust immune response. 
Illustration showing immunology during pregnancy
Infographic: How Immunology Can Influence Pregnancy Outcomes
Tobias R. Kollmann, Arnaud Marchant, and Sing Sing Way | Nov 14, 2022 | 3 min read
Pregnancy-induced changes in the immune system are key to a successful birth. Understanding those changes could allow researchers to protect both mother and child.
Illustration of pregnancy and the immune system
Modulating Immunity to Improve Pregnancy Outcomes
Tobias R. Kollmann, Arnaud Marchant, and Sing Sing Way | Nov 14, 2022 | 10+ min read
Aberrant immune activation, the main cause of prematurity and stillbirths, could be preventable through interventions such as maternal vaccination. 
ADVERTISEMENT